A meta-analysis of eight clinical trials including ELIXA (lixisenatide), LEADER (liraglutide), SUSTAIN-6 (subcutaneous injectable semaglutide), EXSCEL (exenatide), Harmony Outcomes (albiglutide), REWIND (duraglutide), PIONEER-6 (oral administrated semaglutide) and AMPLITUDE-O (efpeglenatide) showed that GLP-1RA reduced MACE by 14% (HR 0.86, 95% CI 0.800.93) [11]
297 Anemoside B4 attenuates colitis symptoms by suppressing the activation of NLRP3 and the phosphorylation of MLC2, which in turn regulates the dysbiosis of the gut microbiota
Liposomal glutathione and N-acetylcysteine (NAC) precursors may improve absorption, but research remains inconclusive
Artesunate and dihydroartemisinin may exert immunomodulatory effects by regulating HMGB1 expression, inhibiting TLR4/NF-B activation, decreasing TNF-, IL-6, IL-1, iNOS, and Cox-2 expression, and attenuating inflammation caused by pneumonia, lung injury, lung fibrosis, and lung cancer (Deng et al., 2018
Association of Amount of Weight Lost After Bariatric Surgery With Intracranial Pressure in Women With Idiopathic Intracranial Hypertension
Compounded tirzepatide is produced by compounding pharmacies using the same active ingredient but without the same regulatory oversight
-1781043799568.png&w=3840&q=75)
